(Q38765734)

6 September 2017

Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication (English)

1 reference

6 September 2017

0 references

1 reference

Shuhei Ueda

1

1 reference

6 September 2017

Hirotaka Ebina

2

1 reference

6 September 2017

Yuka Kanemura

3

1 reference

6 September 2017

Naoko Misawa

4

1 reference

6 September 2017

Yoshio Koyanagi

5

1 reference

6 September 2017

9 June 2016

1 reference

Microbiology and Immunology

6 September 2017

14

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 September 2017

60

1 reference

6 September 2017

7

1 reference

6 September 2017

483-496

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

6 September 2017

1 reference

Persistent HIV-1 replication maintains the tissue reservoir during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

A high excision potential of TALENs for integrated DNA of HIV-based lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

High-efficiency targeted editing of large viral genomes by RNA-guided nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Nuclear architecture dictates HIV-1 integration site selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Genome-scale CRISPR-Cas9 knockout screening in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Characterization of red-capped mangabey tetherin: implication for the co-evolution of primates and their lentiviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

DNA targeting specificity of RNA-guided Cas9 nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

The control of viral infection by tripartite motif proteins and cyclophilin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Retroviral integrase domains: DNA binding and the recognition of LTR sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

Multiplex genome engineering using CRISPR/Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12395

21 January 2018

Identifiers

DOI

10.1111/1348-0421.12395

1 reference

6 September 2017

1 reference